59-AMP-Activated Protein Kinase Attenuates Adriamycin-Induced Oxidative Podocyte Injury through Thioredoxin-Mediated Suppression of the Apoptosis Signal-Regulating Kinase 1-P38 Signaling Pathway

Molecular Pharmacology

Volumn 85, Issue 3, 2014, Pages 460-471

  Gao, Kun ^a,b   Chi, Yuan ^a   Sun, Wei ^b   Takeda, Masayuki ^a   Yao, Jian ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; APOPTOSIS SIGNAL REGULATING KINASE 1; BETA 2 ADRENERGIC RECEPTOR; CALCIUM; CYCLIC AMP; DOXORUBICIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; THIOREDOXIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL LINE; DRUG EFFECT; ENDOCYTOSIS; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PODOCYTE; SIGNAL TRANSDUCTION;

ADRENERGIC AGENTS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; CALCIUM; CELL LINE; CYCLIC AMP; DOXORUBICIN; ENDOCYTOSIS; MAP KINASE KINASE KINASE 5; MAP KINASE SIGNALING SYSTEM; OXIDATION-REDUCTION; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PODOCYTES; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; THIOREDOXINS;

EID: 84894087203     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.089458     Document Type: Article

References (54)

1. Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, and El-Remessy AB (2011) Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol 164:170-180.
2. Andoh T, Chock PB, and Chiueh CC (2002) The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J Biol Chem 277: 9655-9660.
3. Cardaci S, Filomeni G, and Ciriolo MR (2012) Redox implications of AMPK-mediated signal transduction beyond energetic clues. J Cell Sci 125:2115-2125.
4. Carvalho CML, Lu J, Zhang X, Arnér ESJ, and Holmgren A (2011) Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: Implications for treatment of mercury poisoning. FASEB J 25:370-381.
5. Chi Y, Li K, Yan QJ, Koizumi S, Shi LY, Takahashi S, Zhu Y, Matsue H, Takeda M, and Kitamura M et al. (2011) Nonsteroidal anti-inflammatory drug flufenamic acid is a potent activator of AMP-activated protein kinase. J Pharmacol Exp Ther 339: 257-266.
6. Cox AG, Brown KK, Arner ESJ, and Hampton MB (2008) The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochem Pharmacol 76:1097-1109.
7. Du YT, Wu YF, Cao XL, Cui W, Zhang HH, Tian WX, Ji MJ, Holmgren A, and Zhong LW (2009) Inhibition of mammalian thioredoxin reductase by black tea and its constituents: Implications for anticancer actions. Biochimie 91:434-444.
8. Eid AA, Ford BM, Block K, Kasinath BS, Gorin Y, Ghosh-Choudhury G, Barnes JL, and Abboud HE (2010) AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem 285:37503-37512.
9. Fang JG and Holmgren A (2006) Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J Am Chem Soc 128:1879-1885.
10. Fang X, Huang T, Zhu Y, Yan QJ, Chi Y, Jiang JX, Wang PY, Matsue H, Kitamura M, and Yao J (2011) Connexin43 hemichannels contribute to cadmium-induced oxidative stress and cell injury. Antioxid Redox Signal 14:2427-2439.
11. Forman HJ, Fukuto JM, and Torres M (2004) Redox signaling: Thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am J Physiol Cell Physiol 287:C246-C256.
12. Gill PS and Wilcox CS (2006) NADPH oxidases in the kidney. Antioxid Redox Signal 8:1597-1607.
13. Go YM and Jones DP (2010) Redox control systems in the nucleus: Mechanisms and functions. Antioxid Redox Signal 13:489-509.
14. Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Sanchez-Rovira P, and Ramirez-Tortosa MC (2010) New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food Chem Toxicol 48: 1425-1438.
15. Hallows KR, Mount PF, Pastor-Soler NM, and Power DA (2010) Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am J Physiol Renal Physiol 298:F1067-F1077.
16. Hou X, Song J, Li XN, Zhang L, Wang X, Chen L, and Shen YH (2010) Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun 396:199-205.
17. Hsieh CC and Papaconstantinou J (2006) Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice. FASEB J 20:259-268.
18. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, and Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94.
19. Irrcher I, Ljubicic V, and Hood DA (2009) Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells. Am J Physiol Cell Physiol 296:C116-C123.
20. Jones DP (2006) Redefining oxidative stress. Antioxid Redox Signal 8:1865-1879.
21. Kerjaschki D (1994) Dysfunctions of cell biological mechanisms of visceral epithelial cell (podocytes) in glomerular diseases. Kidney Int 45:300-313.
22. Kirkpatrick DL, Kuperus M, Dowdeswell M, Potier N, Donald LJ, Kunkel M, Berggren M, Angulo M, and Powis G (1998) Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. Biochem Pharmacol 55:987-994.
23. Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, and Shimizu F et al. (2005) Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 16:2690-2701.
24. Lee S, Kim SM, and Lee RT (2013) Thioredoxin and thioredoxin target proteins: From molecular mechanisms to functional significance. Antioxid Redox Signal 18: 1165-1207.
25. Li JH, Deane JA, Campanale NV, Bertram JF, and Ricardo SD (2006) Blockade of p38 mitogen-activated protein kinase and TGF-beta1/Smad signaling pathways rescues bone marrow-derived peritubular capillary endothelial cells in adriamycininduced nephrosis. J Am Soc Nephrol 17:2799-2811.
26. Li X, Rong Y, Zhang M, Wang XL, LeMaire SA, Coselli JS, Zhang Y, and Shen YH (2009a) Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. Biochem Biophys Res Commun 381:660-665.
27. Li XN, Song J, Zhang L, LeMaire SA, Hou X, Zhang C, Coselli JS, Chen L, Wang XL, and Zhang Y et al. (2009b) Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes 58:2246-2257.
28. Lin H, Hou CC, Cheng CF, Chiu TH, Hsu YH, Sue YM, Chen TH, Hou HH, Chao YC, and Cheng TH et al. (2007) Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis. Mol Pharmacol 72:1238-1245.
29. Lopert P, Day BJ, and Patel M (2012) Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells. PLoS ONE 7:e50683.
30. Lu J, Vlamis-Gardikas A, Kandasamy K, Zhao R, Gustafsson TN, Engstrand L, Hoffner S, Engman L, and Holmgren A (2013) Inhibition of bacterial thioredoxin reductase: An antibiotic mechanism targeting bacteria lacking glutathione. FASEB J 27:1394-1403.
31. Matsuzawa A and Ichijo H (2008) Redox control of cell fate by MAP kinase: Physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta 1780:1325-1336.
32. Mihaylova MM and Shaw RJ (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13:1016-1023.
33. Morgan WA, Kaler B, and Bach PH (1998) The role of reactive oxygen species in adriamycin and menadione-induced glomerular toxicity. Toxicol Lett 94:209-215.
34. Mungai PT, Waypa GB, Jairaman A, Prakriya M, Dokic D, Ball MK, and Schumacker PT (2011) Hypoxia triggers AMPK activation through reactive oxygen speciesmediated activation of calcium release-activated calcium channels. Mol Cell Biol 31:3531-3545.
35. Murray JW, Thosani AJ, Wang PJ, and Wolkoff AW (2011) Heterogeneous accumulation of fluorescent bile acids in primary rat hepatocytes does not correlate with their homogenous expression of ntcp. Am J Physiol Gastrointest Liver Physiol 301:G60-G68.
36. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, and Yodoi J (1999) Identification of thioredoxin-binding protein-2/ vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274:21645-21650.
37. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, and Fujishima M (1986) Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29:502-510.
38. Papeta N, Zheng Z, Schon EA, Brosel S, Altintas MM, Nasr SH, Reiser J, D'Agati VD, and Gharavi AG (2010) Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice. J Clin Invest 120: 4055-4064.
39. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, and Lee RT (2006) The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 281:21884-21891.
40. Piwkowska A, Rogacka D, Jankowski M, and Angielski S (2011) Extracellular ATP through P2 receptors activates AMP-activated protein kinase and suppresses superoxide generation in cultured mouse podocytes. Exp Cell Res 317:1904-1913.
41. Piwkowska A, Rogacka D, Jankowski M, Dominiczak MH, Stepinski JK, and Angielski S (2010) Metformin induces suppression of NAD(P)H oxidase activity in podocytes. Biochem Biophys Res Commun 393:268-273.
42. Saito Y, Okamura M, Nakajima S, Hayakawa K, Huang T, Yao J, and Kitamura M (2010) Suppression of nephrin expression by TNF-alpha via interfering with the cAMP-retinoic acid receptor pathway. Am J Physiol Renal Physiol 298: F1436-F1444.
43. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17:2596-2606.
44. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, and Chan L et al. (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118:1645-1656.
45. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, and Cantley LC (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642-1646.
46. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, and Witters LA et al. (1996) Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271:611-614.
47. Wang W, Yang X, López de Silanes I, Carling D, and Gorospe M (2003) Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J Biol Chem 278:27016-27023.
48. Wipf P, Hopkins TD, Jung JK, Rodriguez S, Birmingham A, Southwick EC, Lazo JS, and Powis G (2001) New inhibitors of the thioredoxin-thioredoxin reductase system based on a naphthoquinone spiroketal natural product lead. Bioorg Med Chem Lett 11:2637-2641.
49. Wu N, Zheng B, Shaywitz A, Dagon Y, Tower C, Bellinger G, Shen CH, Wen J, Asara J, and McGraw TE et al. (2013) AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell 49: 1167-1175.
50. Yamawaki H, Pan S, Lee RT, and Berk BC (2005) Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 115:733-738.
51. Yan Q, Gao K, Chi Y, Li K, Zhu Y, Wan Y, Sun W, Matsue H, Kitamura M, and Yao J (2012) NADPH oxidase-mediated upregulation of connexin43 contributes to podocyte injury. Free Radic Biol Med 53:1286-1297.
52. Yang L, Zheng SR, and Epstein PN (2009) Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity. Free Radic Res 43:174-182.
53. Yao J, Huang T, Fang X, Chi Y, Zhu Y, Wan YG, Matsue H, and Kitamura M (2010) Disruption of gap junctions attenuates aminoglycoside-elicited renal tubular cell injury. Br J Pharmacol 160:2055-2068.
54. Zhao Y, McLaughlin D, Robinson E, Harvey AP, Hookham MB, Shah AM, McDermott BJ, and Grieve DJ (2010) Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy. Cancer Res 70: 9287-9297.